Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG27401

BLOC1S4 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

BLOC1S4 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from near-haploid HAP1 cells. Disruption of BLOC1S4, a critical BLOC-1 complex subunit, impairs endosomal cargo trafficking to lysosome-related organelles. This model is regulated by the MITF transcription factor and interacts with AP-3 and other BLOC-1 subunits, disrupting autophagy flux and LAMP1-positive organelle distribution. Designed for Hermansky-Pudlak syndrome, lysosomal biology, and autophagy studies, applications include LC3-II/p62 western blotting, LAMP1 immunofluorescence, and co-immunoprecipitation. The polyclonal format provides a robust loss-of-function model for phenotypic screening and pathway analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    BLOC1S4

    Gene Identifier

    NCBI Gene ID 55330

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The BLOC1S4 Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the gene encoding BLOC1S4 has been disrupted. This product provides a loss-of-function model for investigating the BLOC-1 complex subunit BLOC1S4, essential for endosomal trafficking and lysosome-related organelle biogenesis. The polyclonal format offers a heterogeneous knockout pool, ideal for studying gene function without clonal selection bias, and is suitable for functional genomics, pathway analysis, and phenotypic screening.

These cells are derived from the HAP1 cell line, a near-haploid human cell line originally isolated from KBM-7 chronic myeloid leukemia cells. HAP1 cells exhibit adherent growth and contain a single copy of most chromosomes, making them an excellent host for knockout studies by eliminating the complications of diploid gene dosage. Their genetic stability and haploid nature facilitate clear genotype?Cphenotype relationships, particularly for recessive mutations, and they are widely used in genetic screens, mutagenesis studies, and CRISPR-based functional validation.

BLOC1S4 encodes a critical subunit of the biogenesis of lysosome-related organelles complex 1 (BLOC-1), which mediates cargo sorting from early endosomes to lysosome-related organelles such as melanosomes and platelet dense granules. BLOC1S4 forms a complex with BLOC1S1, BLOC1S2, BLOC1S3, BLOC1S5, and BLOC1S6, and interacts with the adaptor protein complex AP-3. The BLOC-1 complex functions downstream of the MITF transcription factor, which regulates its expression, and is essential for proper lysosomal enzyme secretion and autophagy flux. Loss of BLOC1S4 disrupts LAMP1-positive organelle distribution and impairs autophagic degradation, as evidenced by accumulation of LC3-II and p62. Thus, BLOC1S4 is a key node connecting endosomal sorting, lysosomal biogenesis, and autophagy.

Disruption of BLOC1S4 in HAP1 cells creates a powerful model for studying Hermansky-Pudlak syndrome, a disorder characterized by defects in lysosome-related organelle biogenesis. The near-haploid background of HAP1 ensures that knockout effects are not masked by a second functional allele, enabling robust phenotypic assessment. This model recapitulates trafficking deficiencies observed in patient cells, including impaired melanosome maturation and platelet dense granule formation. Additionally, it serves as a platform for investigating lysosomal storage disorders and autophagy-related pathologies, providing insights into how BLOC-1 complex integrity influences cellular clearance mechanisms.

Researchers can employ these BLOC1S4 knockout cells in diverse applications including autophagy flux assays using LC3-II and p62 western blotting, immunofluorescence microscopy for LAMP1/LAMP2 to assess lysosomal distribution, and lysosomal pH measurements. Co-immunoprecipitation experiments can probe BLOC-1 complex assembly and interactions with AP-3. This polyclonal knockout model is particularly suitable for phenotypic screens, drug discovery targeting lysosomal pathways, and studies on endosomal trafficking. For further details or custom inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)